249 related articles for article (PubMed ID: 17040106)
1. Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.
Kurian JR; Chin NA; Longlais BJ; Hayes KL; Trepanier LA
Chem Res Toxicol; 2006 Oct; 19(10):1366-73. PubMed ID: 17040106
[TBL] [Abstract][Full Text] [Related]
2. Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast.
Rhoads K; Sacco JC; Drescher N; Wong A; Trepanier LA
Toxicol Sci; 2011 Jun; 121(2):245-56. PubMed ID: 21447608
[TBL] [Abstract][Full Text] [Related]
3. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans.
Kurian JR; Bajad SU; Miller JL; Chin NA; Trepanier LA
J Pharmacol Exp Ther; 2004 Dec; 311(3):1171-8. PubMed ID: 15302896
[TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of a cytochrome b5 variant in humans with impaired hydroxylamine reduction capacity.
Kurian JR; Longlais BJ; Trepanier LA
Pharmacogenet Genomics; 2007 Aug; 17(8):597-603. PubMed ID: 17622936
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.
Sacco JC; Trepanier LA
Pharmacogenet Genomics; 2010 Jan; 20(1):26-37. PubMed ID: 19997042
[TBL] [Abstract][Full Text] [Related]
6. P450 redox enzymes in the white rot fungus Phanerochaete chrysosporium: gene transcription, heterologous expression, and activity analysis on the purified proteins.
Subramanian V; Doddapaneni H; Syed K; Yadav JS
Curr Microbiol; 2010 Oct; 61(4):306-14. PubMed ID: 20221604
[TBL] [Abstract][Full Text] [Related]
7. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous purification and characterization of cytochrome b5 reductase and cytochrome b5 from sheep liver.
Arinç E; Cakir D
Int J Biochem Cell Biol; 1999 Feb; 31(2):345-62. PubMed ID: 10216966
[TBL] [Abstract][Full Text] [Related]
9. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
10. Microsomal NADH-cytochrome b5 reductase of bovine brain: purification and properties.
Tamura M; Yubisui T; Takeshita M
J Biochem; 1983 Nov; 94(5):1547-55. PubMed ID: 6654871
[TBL] [Abstract][Full Text] [Related]
11. Bioactivation of the tobacco carcinogens 4-aminobiphenyl (4-ABP) and 2-amino-9H-pyrido[2,3-b]indole (AαC) in human bladder RT4 cells.
Bellamri M; Yao L; Bonala R; Johnson F; Von Weymarn LB; Turesky RJ
Arch Toxicol; 2019 Jul; 93(7):1893-1902. PubMed ID: 31203411
[TBL] [Abstract][Full Text] [Related]
12. Transient kinetics of intracomplex electron transfer in the human cytochrome b5 reductase-cytochrome b5 system: NAD+ modulates protein-protein binding and electron transfer.
Meyer TE; Shirabe K; Yubisui T; Takeshita M; Bes MT; Cusanovich MA; Tollin G
Arch Biochem Biophys; 1995 Apr; 318(2):457-64. PubMed ID: 7733677
[TBL] [Abstract][Full Text] [Related]
13. Heterologous expression and mechanistic investigation of a fungal cytochrome P450 (CYP5150A2): involvement of alternative redox partners.
Ichinose H; Wariishi H
Arch Biochem Biophys; 2012 Feb; 518(1):8-15. PubMed ID: 22206618
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of myricetin, morin, apigenin, (+)-taxifolin, (+)-catechin, (-)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 reductase.
Çelik H; Koşar M; Arinç E
Toxicology; 2013 Jun; 308():34-40. PubMed ID: 23567315
[TBL] [Abstract][Full Text] [Related]
15. Fractionation of liver microsomes with polyethylene glycol and purification of NADH-cytochrome b5 oxidoreductase and cytochrome b5.
Yang MX; Cederbaum AI
Arch Biochem Biophys; 1994 Dec; 315(2):438-44. PubMed ID: 7986089
[TBL] [Abstract][Full Text] [Related]
16. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases.
Butler MA; Guengerich FP; Kadlubar FF
Cancer Res; 1989 Jan; 49(1):25-31. PubMed ID: 2908851
[TBL] [Abstract][Full Text] [Related]
17. Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative.
King RS; Teitel CH; Shaddock JG; Casciano DA; Kadlubar FF
Cancer Lett; 1999 Sep; 143(2):167-71. PubMed ID: 10503898
[TBL] [Abstract][Full Text] [Related]
18. Interaction of ferric complexes with NADH-cytochrome b5 reductase and cytochrome b5: lipid peroxidation, H2O2 generation, and ferric reduction.
Yang MX; Cederbaum AI
Arch Biochem Biophys; 1996 Jul; 331(1):69-78. PubMed ID: 8660685
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of the naturally fused CS and cytochrome b
Benson DR; Lovell S; Mehzabeen N; Galeva N; Cooper A; Gao P; Battaile KP; Zhu H
Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):628-638. PubMed ID: 31282472
[TBL] [Abstract][Full Text] [Related]
20. Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes.
Zhang H; Gao N; Liu T; Fang Y; Qi B; Wen Q; Zhou J; Jia L; Qiao H
PLoS One; 2015; 10(6):e0128547. PubMed ID: 26046844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
